JP2000514090A - 精製方法 - Google Patents
精製方法Info
- Publication number
- JP2000514090A JP2000514090A JP10533299A JP53329998A JP2000514090A JP 2000514090 A JP2000514090 A JP 2000514090A JP 10533299 A JP10533299 A JP 10533299A JP 53329998 A JP53329998 A JP 53329998A JP 2000514090 A JP2000514090 A JP 2000514090A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- aminothiazol
- vinyl
- cephem
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 19
- 238000000746 purification Methods 0.000 title description 5
- -1 aminothiazol-4-yl Chemical group 0.000 claims abstract description 145
- 150000003839 salts Chemical class 0.000 claims abstract description 90
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims abstract description 85
- 150000001875 compounds Chemical class 0.000 claims abstract description 68
- IPYWNMVPZOAFOQ-NABDTECSSA-N (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;trihydrate Chemical compound O.O.O.S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 IPYWNMVPZOAFOQ-NABDTECSSA-N 0.000 claims abstract description 42
- 229960002129 cefixime Drugs 0.000 claims abstract description 42
- 239000012453 solvate Substances 0.000 claims abstract description 28
- 150000001412 amines Chemical class 0.000 claims abstract description 21
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims abstract description 18
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract description 17
- 150000004684 trihydrates Chemical class 0.000 claims abstract description 11
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 38
- 239000001257 hydrogen Substances 0.000 claims description 38
- 229910052739 hydrogen Inorganic materials 0.000 claims description 37
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 32
- 125000000217 alkyl group Chemical group 0.000 claims description 31
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 150000002431 hydrogen Chemical class 0.000 claims description 19
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 18
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims description 17
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 16
- 125000003118 aryl group Chemical group 0.000 claims description 14
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 13
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims description 11
- GQLGFBRMCCVQLU-XCGJVMPOSA-N (6r)-7-amino-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(C=C)=C(C(O)=O)N2C(=O)C(N)[C@H]21 GQLGFBRMCCVQLU-XCGJVMPOSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 125000002252 acyl group Chemical group 0.000 claims description 9
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 9
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- HHKMXEGJWMSEDD-UHFFFAOYSA-N CC(OC1=NC2=CC=CC=C2[S+]1S)=O Chemical compound CC(OC1=NC2=CC=CC=C2[S+]1S)=O HHKMXEGJWMSEDD-UHFFFAOYSA-N 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 239000000052 vinegar Substances 0.000 claims description 3
- 235000021419 vinegar Nutrition 0.000 claims description 3
- MAUHLWUADQYTDD-XCGJVMPOSA-N (6r)-4-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CC(C=C)S[C@@H]2CC(=O)N12 MAUHLWUADQYTDD-XCGJVMPOSA-N 0.000 claims 1
- 150000002148 esters Chemical class 0.000 abstract description 10
- 238000002360 preparation method Methods 0.000 abstract description 3
- OKBVVJOGVLARMR-LNUXAPHWSA-N (6r)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1C(N)=NC(C(=NOCC(O)=O)C(=O)NC2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-LNUXAPHWSA-N 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 32
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 27
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 239000011541 reaction mixture Substances 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- 239000013078 crystal Substances 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- 238000001914 filtration Methods 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 150000004682 monohydrates Chemical class 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- QIJIUJYANDSEKG-UHFFFAOYSA-N 2,4,4-trimethylpentan-2-amine Chemical compound CC(C)(C)CC(C)(C)N QIJIUJYANDSEKG-UHFFFAOYSA-N 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- 229920002554 vinyl polymer Polymers 0.000 description 7
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 6
- 239000004327 boric acid Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000006184 cosolvent Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 5
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 125000000335 thiazolyl group Chemical group 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000005917 acylation reaction Methods 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 3
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 2
- DCRDZICLFLDBFN-UHFFFAOYSA-N 5-phenyl-n-pyrazin-2-yl-1,3-thiazol-2-amine Chemical compound C=1N=CC=NC=1NC(S1)=NC=C1C1=CC=CC=C1 DCRDZICLFLDBFN-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001024304 Mino Species 0.000 description 2
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229940047583 cetamide Drugs 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- XEZIFGWTSLOMMT-MEFGMAGPSA-N (2z)-2-(2-amino-1,3-thiazol-4-yl)-2-trityloxyiminoacetic acid Chemical compound S1C(N)=NC(C(=N\OC(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)\C(O)=O)=C1 XEZIFGWTSLOMMT-MEFGMAGPSA-N 0.000 description 1
- CQQOTVOIZVQRRM-LRHAYUFXSA-N (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]iminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)CON=C(C(=O)NC1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O)c1csc(N)n1 CQQOTVOIZVQRRM-LRHAYUFXSA-N 0.000 description 1
- BYZFLPNJLJGOHB-SSDOTTSWSA-N (6r)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=C(C=C)CS[C@@H]2CC(=O)N12 BYZFLPNJLJGOHB-SSDOTTSWSA-N 0.000 description 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 1
- MTPOIJDLKCVHGS-UHFFFAOYSA-N 2,4,4-trimethylpentan-2-amine Chemical compound CC(C)(C)CC(C)(C)N.CC(C)(C)CC(C)(C)N MTPOIJDLKCVHGS-UHFFFAOYSA-N 0.000 description 1
- BTBQXVJMMALOJT-UHFFFAOYSA-N 2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetic acid Chemical compound NC1=NC(C(=NOCC(O)=O)C(O)=O)=CS1 BTBQXVJMMALOJT-UHFFFAOYSA-N 0.000 description 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 150000003869 acetamides Chemical class 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical class CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000005103 alkyl silyl group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 229950003476 aminothiazole Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000012296 anti-solvent Substances 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 229940047284 cefix Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 1
- AFZSMODLJJCVPP-UHFFFAOYSA-N dibenzothiazol-2-yl disulfide Chemical compound C1=CC=C2SC(SSC=3SC4=CC=CC=C4N=3)=NC2=C1 AFZSMODLJJCVPP-UHFFFAOYSA-N 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- IYWCBYFJFZCCGV-UHFFFAOYSA-N formamide;hydrate Chemical compound O.NC=O IYWCBYFJFZCCGV-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N methyl monoether Natural products COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 式: のセフィキシムの製造方法であって、 a.式: (式中、R5及びR6は、水素又は離脱基を示し、R7は、水素、アルキル、シク ロアルキル、アルキルアリール、アリール、アリールアルキル又はシリルを示す ) の7−アミノ−3−ビニル−3−セフェム−4−カルボン酸を、式: (式中、R9は、アルキル、シクロアルキル、アルキルアリール、アリール又は アリールアルキルを示し、R10は水素を示し、そしてR11は、水素、シリル又は アシルを示す) の2−(アミノチアゾール−4−イル)−2−(カルボキシメトキシイミノ)酢 酸と反応させて、式:(式中、R7、R9、R10及びR11は、前記定義された通りである) の7−[2−(アミノチアゾール−4−イル)−2−(カルボキシメトキシイミ ノ)アセトアミド]−3−ビニル−3−セフェム−4−カルボン酸を得る工程、 b.式IA(式中、R7、R9、R10及びR11は、前記定義された通りである) の7−[2−(アミノチアゾール−4−イル)−2−(カルボキシメトキシイミ ノ)アセトアミド]−3−ビニル−3−セフェム−4−カルボン酸を、式: (式中、R1、R2及びR3はお互いに独立に、水素、アルキル、シクロアルキル 、アルキルアリール、アリール又はアラルキルを示す) のアミンと反応させて、式IA(式中、R7、R9、R10及びR11は、前記定義さ れた通りである)の化合物と、式VI(式中、R1、R2及びR3は、前記定義さ れた通りである)のアミンとの結晶性塩を得る工程、 c.式IA(式中、R7、R9、R10及びR11は、前記定義された通りである) の7−[2−(アミノチアゾール−4−イル)−2−(カルボキシメトキシイミ ノ)アセトアミド]−3−ビニル−3−セフェム−4−カルボン酸を、硫酸と反 応させて、結晶性硫酸付加塩の形態で、式(式中、R7、R10及びR11は、前記定義された通りである)の化合物を得る工 程、並びに、所望により、 d.式IIA(式中、R7、R10及びR11は、前記定義された通りである)の 7−[2−(アミノチアゾール−4−イル)−2−(カルボキシメトキシイミノ )アセトアミド]−3−ビニル−3−セフェム−4−カルボン酸の硫酸付加塩を 、式IIのセフィキシムに変換する工程 を含む方法。 2. 式IIIAの化合物が、式: の7−アミノ−3−ビニル−3−セフェム−4−カルボン酸である、請求項1記 載の方法。 3. 式IVAの化合物が、N,N−ジアセトアミド溶媒和物の形態である、式 : の2−(アミノチアゾール−4−イル)−2−(tert−ブトキシカルボニル メトキシイミノ)酢酸 S−メルカプトベンゾ−チアゾリルエステルである、請 求項1又は2記載の方法。 4. 式IIのセフィキシムが三水和物の形態である、請求項1〜3の何れか1 項記載の方法。 5. N,N−ジメチルアセトアミド溶媒和物の形の、式の2−(アミノチアゾ ール−4−イル)−2−(tert−ブトキシカルボニルメトキシイミノ)酢酸 S−メルカプトベンゾ−チアゾリルエステル。 6. 式IA(式中、R7、R9、R10及びR11は、請求項1に定義された通りで ある)の7−[2−(アミノチアゾール−4−イル)−2−(カルボキシメトキ シイミノ)アセトアミド]−3−ビニル−3−セフェム−4−カルボン酸と、式 VI(式中、R1、R2及びR3は、請求項1に定義された通りである)のアミン との結晶性塩。 7. 式IAの7−[2−(アミノチアゾール−4−イル)−2−(カルボキシ メトキシイミノ)アセトアミド]−3−ビニル−3−セフェム−4−カルボン酸 が、式: の7−[2−(アミノチアゾール−4−イル)−2−(ブトキシカルボニルメト キシイミノ)アセトアミド]−3−ビニル−3−セフェム−4−カルボン酸であ る、請求項6記載の塩。 8. 式Iの7−[2−(アミノチアゾール−4−イル)−2−(tert−ブ トキシカルボニルメトキシイミノ)アセトアミド]−3−ビニル−3−セフェム −4−カルボン酸と、トリエチルアミン、ジシクロヘキシルアミン又はtert −オクチルアミンとの塩である、請求項6〜7の何れか1項記載の塩。 9. 式IIA(式中、R7、R10及びR11は、請求項1に定義された通りであ る)の化合物の硫酸付加塩。 10. 式IIAの化合物が式IIのセフィキシムである、請求項9記載の塩。 11. 式IIのセフィキシムの製造方法に於ける、N,N−ジメチルアセトア ミド溶媒和物の形の、2−(アミノチアゾ−ル−4−イル)−2−(tert− ブトキシカルボニルメトキ シイミノ)酢酸 S−メルカプトベンゾ−チアゾリルエステル、及び式IA(式 中、R7、R9、R10及びR11は、請求項1に定義された通りである)の7−[2 −(アミノチアゾール−4−イル)−2−(カルボキシメトキシイミノ)アセト アミド]−3−ビニル−3−セフェム−4−カルボン酸と、式VI(式中、R1 、R2及びR3は、請求項1に定義された通りである)のアミンとの結晶性塩、及 び式IIA(式中、R7、R10及びR11は、請求項1に定義された通りである) の化合物の硫酸付加塩の使用。 12. 式: (式中、R1、R2及びR3はそれぞれエチル基を示すか、又はR1及びR2はシク ロヘキシルでありR3は水素であるか、又はR1及びR2は水素でありR3はter t−オクチル基である) の7−[2−(アミノチアゾール−4−イル)−2−(tert−ブトキシカル ボニルメトキシイミノ)アセトアミド]−3− ビニル−3−セフェム−4−カルボン酸の結晶性塩。 13. 式: のセフィキシムの結晶性塩。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT61/97 | 1997-01-16 | ||
AT62/97 | 1997-01-16 | ||
AT6197A AT404726B (de) | 1997-01-16 | 1997-01-16 | Kristalline salze von derivaten der 3-vinyl-3-cephem-4-carbonsäure und verfahren zu deren herstellung |
AT0006297A AT404727B (de) | 1997-01-16 | 1997-01-16 | Kristallines salz von cefixim und verfahren zu dessen herstellung |
PCT/EP1998/000190 WO1998031685A1 (en) | 1997-01-16 | 1998-01-14 | Purification process |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004010146A Division JP2004155793A (ja) | 1997-01-16 | 2004-01-19 | 精製方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000514090A true JP2000514090A (ja) | 2000-10-24 |
Family
ID=25591299
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10533299A Pending JP2000514090A (ja) | 1997-01-16 | 1998-01-14 | 精製方法 |
JP2004010146A Pending JP2004155793A (ja) | 1997-01-16 | 2004-01-19 | 精製方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004010146A Pending JP2004155793A (ja) | 1997-01-16 | 2004-01-19 | 精製方法 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0968214B1 (ja) |
JP (2) | JP2000514090A (ja) |
KR (1) | KR20000070275A (ja) |
AR (1) | AR011072A1 (ja) |
AU (1) | AU6614198A (ja) |
DE (1) | DE69823012T2 (ja) |
ES (1) | ES2219874T3 (ja) |
HK (1) | HK1024698A1 (ja) |
TW (1) | TW538045B (ja) |
WO (1) | WO1998031685A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004096785A1 (ja) * | 2003-04-25 | 2004-11-11 | Nippon Chemiphar Co., Ltd. | (2s,3s)-3-[[(1s)-1-イソブトキシメチル-3-メチルブチル]カルバモイル]オキシラン-2-カルボン酸の塩 |
JP2006501305A (ja) * | 2002-10-01 | 2006-01-12 | アンティビオーティコス エッセ.ピ.ア. | セフジニル中間体塩 |
JP2008189688A (ja) * | 2001-06-05 | 2008-08-21 | Hanmi Pharm Co Ltd | 結晶性セフジニル酸付加塩及びこれを用いたセフジニルの製造方法 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT102061B (pt) * | 1997-10-08 | 2000-06-30 | J K Ind Ltd | Processo de preparacao de um antibiotico cefalosporina geralmente activo-cefixime |
AT406773B (de) * | 1998-04-02 | 2000-08-25 | Biochemie Gmbh | Neues salz von 7-(2-(aminothiazol-4yl)-2- |
KR100377556B1 (ko) * | 1999-01-27 | 2003-03-26 | 주식회사 엘지생명과학 | 세픽심 제조에 유용한 중간체의 제조방법 |
EP1178992A2 (en) | 1999-05-07 | 2002-02-13 | Ranbaxy Laboratories, Limited | Process for the preparation of cefpodoxime acid |
KR100342600B1 (ko) | 2000-03-06 | 2002-07-04 | 한미정밀화학주식회사 | 신규한 티아졸 화합물 및 그의 제조 방법 |
KR100392409B1 (ko) * | 2000-03-20 | 2003-07-22 | 한미정밀화학주식회사 | 신규한 티아졸 화합물을 이용한 세팔로스포린계항생물질의 제조 방법 |
ITMI20012364A1 (it) * | 2001-11-09 | 2003-05-09 | Antibioticos Spa | Processo di sintesi della cefixima via alchil-o arilsolfonati |
EP1863822B1 (en) | 2005-03-29 | 2009-10-14 | Hetero Drugs Limited | An improved process for the preparation of cefixime |
CN102311452B (zh) * | 2011-09-22 | 2013-07-03 | 山东罗欣药业股份有限公司 | 头孢克肟晶体、其制备方法及含有该晶体的片剂组合物 |
CN103087080B (zh) * | 2011-11-03 | 2016-08-31 | 石药集团中奇制药技术(石家庄)有限公司 | 一种盐酸头孢卡品酯的制备方法及其合成中间体 |
CN107056815B (zh) * | 2017-06-16 | 2019-06-25 | 成都倍特药业有限公司 | 一种头孢克肟及精制方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4409214A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical, Co., Ltd. | 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof |
-
1998
- 1998-01-07 TW TW087100131A patent/TW538045B/zh not_active IP Right Cessation
- 1998-01-14 DE DE69823012T patent/DE69823012T2/de not_active Expired - Fee Related
- 1998-01-14 ES ES98907945T patent/ES2219874T3/es not_active Expired - Lifetime
- 1998-01-14 EP EP98907945A patent/EP0968214B1/en not_active Expired - Lifetime
- 1998-01-14 AR ARP980100163A patent/AR011072A1/es unknown
- 1998-01-14 WO PCT/EP1998/000190 patent/WO1998031685A1/en not_active Application Discontinuation
- 1998-01-14 AU AU66141/98A patent/AU6614198A/en not_active Abandoned
- 1998-01-14 KR KR1019997006503A patent/KR20000070275A/ko not_active Application Discontinuation
- 1998-01-14 JP JP10533299A patent/JP2000514090A/ja active Pending
-
2000
- 2000-07-04 HK HK00104089A patent/HK1024698A1/xx not_active IP Right Cessation
-
2004
- 2004-01-19 JP JP2004010146A patent/JP2004155793A/ja active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008189688A (ja) * | 2001-06-05 | 2008-08-21 | Hanmi Pharm Co Ltd | 結晶性セフジニル酸付加塩及びこれを用いたセフジニルの製造方法 |
JP2006501305A (ja) * | 2002-10-01 | 2006-01-12 | アンティビオーティコス エッセ.ピ.ア. | セフジニル中間体塩 |
WO2004096785A1 (ja) * | 2003-04-25 | 2004-11-11 | Nippon Chemiphar Co., Ltd. | (2s,3s)-3-[[(1s)-1-イソブトキシメチル-3-メチルブチル]カルバモイル]オキシラン-2-カルボン酸の塩 |
JPWO2004096785A1 (ja) * | 2003-04-25 | 2006-07-13 | 日本ケミファ株式会社 | (2s,3s)−3−[[(1s)−1−イソブトキシメチル−3−メチルブチル]カルバモイル]オキシラン−2−カルボン酸の塩 |
AU2011201257B2 (en) * | 2003-04-25 | 2013-03-21 | Velcura Therapeutics, Inc. | Salt of (2S,3S)-3-[[(1S)-1-isobutoxymethyl-3-methylbutyl]carbamoyl]oxirane-2-carboxylic acid |
Also Published As
Publication number | Publication date |
---|---|
DE69823012T2 (de) | 2005-03-24 |
TW538045B (en) | 2003-06-21 |
ES2219874T3 (es) | 2004-12-01 |
WO1998031685A1 (en) | 1998-07-23 |
KR20000070275A (ko) | 2000-11-25 |
AU6614198A (en) | 1998-08-07 |
EP0968214A1 (en) | 2000-01-05 |
EP0968214B1 (en) | 2004-04-07 |
AR011072A1 (es) | 2000-08-02 |
JP2004155793A (ja) | 2004-06-03 |
HK1024698A1 (en) | 2001-01-12 |
DE69823012D1 (de) | 2004-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3421354B2 (ja) | 結晶性セフジニルアミン塩 | |
JP2000514090A (ja) | 精製方法 | |
JPH0313237B2 (ja) | ||
JPH02311483A (ja) | セフトリアキソンの製造方法 | |
JPH05247013A (ja) | アミノチアゾリル酢酸の新規なオキシム誘導体及びその製造法 | |
JP4192599B2 (ja) | アミノチアゾール誘導体の無水物の製造方法 | |
JPH0419229B2 (ja) | ||
CA2326441C (en) | Process for purification of a cephalosporin derivative | |
JPS59130889A (ja) | 新規なセフアロスポリン中間体 | |
JP3911124B2 (ja) | セフポドキシムプロクセチルジアステレオ異性体の調製プロセス | |
JPH10511377A (ja) | セフォタキシムの製造 | |
US20040092735A1 (en) | Process for the preparation of cefuroxime sodium | |
JPS6118786A (ja) | セフタジダイムの改良結晶化法 | |
JP4022070B2 (ja) | 新規チアゾール化合物およびその製造方法 | |
JPH11510812A (ja) | 精製方法 | |
US3507860A (en) | Process for the purification of crude 7-aminocephalosporanic acid and acid addition salts of 7 - amino - cephalosporanic acid employed therein | |
JP5047418B2 (ja) | 結晶β−ラクタム中間体 | |
HU213267B (en) | Process for producing stereospecific cefepime-dihydrochloride-hydrate at ph 5-7,5 | |
HU212782B (en) | Water-free acylating process for stereospecifical producing antibioticum cephepim-dihydrochloride-hydrate | |
HU180687B (en) | Process for preparing 7-acyl-amido-ceph-3-eme-4-carboxylic acid derivatives | |
US20060009639A1 (en) | Process for the preparation of cefpodoxime proxetil | |
WO2006010978A1 (en) | Cefdinir polymorphic forms, and imidazole salt | |
KR100472048B1 (ko) | 아즈트레오남의 신규제조방법 | |
FI72123B (fi) | 7-/d(-)-alfa-(4-etyl-2,3-dioxo-1-piperazinkarboxiamido)-alfa-(4-hydroxifenyl)acetamido/-3-/5-(1-metyl-1,2,3,4-tetrazolyl)tiometyl/- 3-cefem-4-karboxylsyrans n,n-dimetylacetamidadduktoch foerfarande foer framstaellning av denna | |
KR960011779B1 (ko) | 세팔로스포린 결정성 수화물의 신규 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040119 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040316 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040709 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20040805 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20040819 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20041124 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050304 |